1 filter applied. Clear filter
Op-Ed
America needs a confirmed leader at FDA — now
Mark McClellan, Scott Gottlieb, and Margaret Hamburg and Andy Slavitt
2022
Read MorePolicy Brief
Enhancing the Accessibility and Utility of Drug Interaction Information in Prescription Drug Labeling
Nicholas R. Harrison, Sarah M. Sheehan, Mongthuong T. Tran, Jeanne Herndon, Eric
Brodsky, and Joseph A. Grillo
2021
Read MoreLetter
FDA Commissioners Letter of Support for Rob Califf
Andrew von Eschenbach, MD, Scott Gottlieb, MD, Stephen Hahn, MD, Margaret Hamburg, MD, Jane Henney, MD, Mark McClellan, MD PhD
2021
Read MoreProject Report
Characterizing the FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle
Nicholas R. Harrison and Sarah Sheehan
2020
Read More